To conclude, this is the first evidence suggesting that a polymorphism in HIF1A gene (rs2057482) has significant impact on clinical outcome in Chinese HCC patients, especially among patients with advantage stage or some other aggressive clinical status. Here, HIF1A is linked to hepatocellular carcinoma.